Skip to main content
Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc. — Investor Relations & Filings

Ticker · 2500 ISIN · CNE100003PJ8 HKEX Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2024-07-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2500

About Venus Medtech (Hangzhou) Inc.

http://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc. is an innovation-driven medical device company specializing in the research, development, manufacturing, and commercialization of transcatheter solutions for structural heart diseases. The company focuses on bioprosthetic heart valves, establishing a comprehensive pipeline that addresses aortic, pulmonary, mitral, and tricuspid valve diseases. Its product portfolio includes transcatheter aortic valve replacement (TAVR) solutions, and it is committed to addressing unmet demand in TPVR and TMVR. The company also develops solutions for hypertension, such as renal artery denervation ablation, and related surgical accessory products. Its products are commercialized globally, reaching over 60 countries and regions across Asia, Europe, and the Americas.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 June 2024. It details movements in authorised/registered share capital, issued shares, treasury shares, share options, and repurchases. It includes confirmations pursuant to specific Hong Kong Stock Exchange listing rules. The document is a regulatory submission reporting share capital and share movement details for a specific month, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a regulatory filing itself. Therefore, it fits best under Regulatory Filings (RNS). The document length (over 10,000 characters) and detailed data confirm it is not a brief announcement or certification only.
2024-07-04 English
POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the 2023 Annual General Meeting (AGM) of Venus Medtech (Hangzhou) Inc. It details the voting outcomes on various resolutions including approval of the 2023 annual report, work reports, profit distribution plan, and auditor re-appointment. The document does not contain the full annual report or detailed financial statements but rather the official voting results from the AGM. It references the circular dated June 7, 2024, and confirms the resolutions were passed. The document length is 5612 characters, which is relatively short and focused on voting results rather than the full report. Therefore, this fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-28 English
VOLUNTARY ANNOUNCEMENT VENUSP-VALVE COMPLETED FIRST PATIENT IMPLANTATION IN IDE PIVOTAL CLINICAL TRIAL IN U.S.
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Venus Medtech (Hangzhou) Inc. about the completion of the first patient implantation in a pivotal clinical trial for their VenusP-Valve device in the U.S. It discusses clinical trial progress, regulatory approvals, and market potential. There are no financial statements, earnings data, or detailed financial analysis. The document is an announcement of a clinical milestone and regulatory progress rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being attached or published. It is also not related to board changes, voting results, or capital changes. The content fits best under a general regulatory announcement category as it informs the market about significant company developments without financial data or formal report structure.
2024-06-14 English
Notification Letter to Non-Registered Holders - Notice of Publication of Circular of Annual General Meeting and Reply Form
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Venus Medtech (Hangzhou) Inc. dated June 7, 2024, informing non-registered shareholders about the publication of the Circular of the Annual General Meeting (AGM). It explains the electronic dissemination of corporate communications including directors' reports, annual accounts, auditors' reports, interim reports, notices of meetings, listing documents, circulars, and proxy forms. The letter provides instructions on how shareholders can access these documents electronically or request printed copies. It also includes a reply form for shareholders to request printed communications. The document does not contain any financial statements, detailed financial data, or management discussion and analysis. It is essentially an announcement about the availability and distribution method of corporate communications, specifically the AGM circular, rather than the AGM materials themselves or any financial report. The document is over 12,000 characters but is primarily a notification and request form. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) rather than the actual AGM Information or Annual Report. The document is not a regulatory filing or certification, nor does it fit other categories such as earnings release or management report. Hence, the most appropriate classification is RPA with high confidence.
2024-06-07 English
Notification Letter to Registered Shareholders - Notice of Publication of Circular and Proxy Form of Annual General Meeting and Reply Form
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Venus Medtech (Hangzhou) Inc. to its registered shareholders regarding the publication of the circular and proxy form for the Annual General Meeting (AGM). It explains the electronic dissemination of corporate communications, including annual reports, interim reports, notices of meetings, circulars, and proxy forms. The document also includes a reply form for shareholders to choose how they wish to receive future corporate communications (electronically or in printed form). The document does not contain any financial statements, audit reports, or detailed financial data itself; rather, it announces the availability of these materials and provides instructions for shareholders to access them. The document is lengthy (over 14,000 characters) but is clearly an announcement about the publication and distribution of corporate communications related to the AGM, not the AGM materials themselves. Therefore, it fits the category of Report Publication Announcement (RPA).
2024-06-07 English
PROXY FORM FOR USE AT THE 2023 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a proxy form for the 2023 Annual General Meeting (AGM) of Venus Medtech (Hangzhou) Inc. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including approval of the 2023 annual report, board and supervisory committee work reports, profit distribution plan, and auditor re-appointment. The content is focused on voting procedures and proxy appointment rather than the actual annual report or financial data. This type of document is typically classified as AGM Information (AGM-R) because it is a material shared for use at the AGM, not the report itself or an announcement of the report publication.
2024-06-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.